title: Management of unstable angina soon after myocardial infarction.
abstract: The recurrence of angina soon after myocardial infarction is not uncommon and represents areas of viable myocardium at risk from infarct extension and thus a worse prognosis. A better understanding of the pathogenesis of acute ischaemic syndromes and developments in interventional cardiology in the past decade have helped us rationalize our approach to this high-risk subset and achieve maximal myocardial salvage with its short- and long-term benefits.
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000628:therapy*; D000789:Angina, Unstable / Q000503:physiopathology / Q000628:therapy*; D000800:Angioplasty, Balloon; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction; D009206:Myocardium / Q000378:metabolism; D009566:Nitrates / Q000627:therapeutic use; D010101:Oxygen Consumption; D011379:Prognosis
chemical_list: D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D009566:Nitrates; D001241:Aspirin